A novel epithelial sodium channel beta-subunit mutation associated with hypertensive Liddle syndrome

Pediatr Nephrol. 2005 Apr;20(4):512-5. doi: 10.1007/s00467-004-1751-2. Epub 2005 Feb 3.

Abstract

Low-renin hypertension responsive to amiloride-thiazide therapy in a 4-year-old Afro-Haitian girl suggested Liddle syndrome. Urine steroid profiling substantiated the diagnosis and DNA analysis of the epithelial sodium channel (ENaC) revealed a novel heterozygous beta ENaC mutation in the patient and in her hypertensive father. Liddle syndrome should be considered as a cause of hypertension in young children particularly with suppressed renin activity.

Publication types

  • Case Reports

MeSH terms

  • Amiloride / therapeutic use
  • Amino Acid Substitution
  • Base Sequence
  • Child, Preschool
  • Diuretics / therapeutic use
  • Drug Therapy, Combination
  • Epithelial Sodium Channels
  • Female
  • Heterozygote
  • Histidine
  • Humans
  • Hydrochlorothiazide / therapeutic use
  • Hypertension / blood
  • Hypertension / diet therapy
  • Hypertension / drug therapy
  • Hypertension / etiology
  • Mutation*
  • Proline
  • Protein Isoforms / genetics
  • Pseudohypoaldosteronism / complications
  • Pseudohypoaldosteronism / genetics*
  • Renin / blood
  • Sodium Channels / genetics*
  • Sodium Chloride Symporter Inhibitors / therapeutic use

Substances

  • Diuretics
  • Epithelial Sodium Channels
  • Protein Isoforms
  • SCNN1B protein, human
  • Sodium Channels
  • Sodium Chloride Symporter Inhibitors
  • Hydrochlorothiazide
  • Histidine
  • Amiloride
  • Proline
  • Renin